Roles of P67/MetAP2 as a tumor suppressor

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1796, Issue 2, 2009, Pages 281-292

  Datta, Bansidhar ^a  

^a KENT STATE UNIVERSITY   (United States)

Author keywords

Angiogenesis; EIF 2 associated glycoprotein, p67 MetAP2; eIF2 phosphorylation; ERK1 2, extracellular signal regulated kinases; p67 MetAP2 inhibitors; Tumorigenesis

Indexed keywords

A 310840; A 311263; A 357300; A 800141; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; BESTATIN DERIVATIVE; BETA AMINO ALPHA HYDROXYAMIDE DERIVATIVE; FUMAGILLIN; FUMAGILLOL CHLOROACETYLCARBAMATE; INITIATION FACTOR 2; INITIATION FACTOR 2ALPHA; MESSENGER RNA; METHIONYL AMINOPEPTIDASE 2; MITOGEN ACTIVATED PROTEIN KINASE 3; NIP 71; OVALICIN; PPI 2458; SULFONAMIDE; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; CANCER CELL; CANCER CELL CULTURE; CANCER TISSUE; CLINICAL TRIAL; DRUG MEGADOSE; DRUG PROTEIN BINDING; DRUG RESPONSE; DRUG STRUCTURE; ENZYME ACTIVITY; EUKARYOTE; HUMAN; MELANOMA; MUTATIONAL ANALYSIS; NEUROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROKARYOTE; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; TUMOR SUPPRESSOR GENE;

AMINO ACID SEQUENCE; AMINOPEPTIDASES; ANIMALS; CYCLOHEXANES; EUKARYOTIC INITIATION FACTOR-2; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FATTY ACIDS, UNSATURATED; GLYCOPROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; SESQUITERPENES; TUMOR SUPPRESSOR PROTEINS;

EUKARYOTA; MAMMALIA;

EID: 70349290496     PISSN: 0304419X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbcan.2009.08.002     Document Type: Review

References (102)

1. Datta B. MAPs and POEP of the roads from prokaryotic to eukaryotic kingdoms. Biochimie 82 (2000) 95-107
2. Datta B., Datta R., Ghosh A., and Majumdar A. Eukaryotic initiation factor 2-associated glycoprotein, p67, shows differential effects on the activity of certain kinases during serum-starved conditions. Arch. Biochem. Biophys. 427 (2004) 68-78
3. Datta B., Datta R., Majumdar A., and Balusu R. Treatment of cells with the angiogenic inhibitor fumagillin results in increased stability of eukaryotic initiation factor 2-associated glycoprotein, p67, and reduced phosphorylation of extracellular signal-regulated kinases 1 and 2. Biochemistry 43 (2004) 14821-14831
4. Datta B., Datta R., Ghosh A., and Majumdar A. The stability of eukaryotic initiation factor 2-associated glycoprotein, p67, increases during skeletal muscle differentiation and that inhibits the phosphorylation of extracellular signal-regulated kinases 1 and 2. Exp. Cell Res. Exp. Cell Res. 303 (2005) 174-182
5. Bradshaw R.A., and Yi E. Methionine aminopeptidases and angiogenesis. Essays in Biochem. 38 (2002) 65-78
6. Gao Y., Wells L., Comer F.I., Parker G.J., and Hart G.W. Dynamic O-glycosylation of nuclear and cytoplasmic proteins: cloning and characterization of a neutral, cytoplasmic beta-N-acetylglucosaminidase from human brain. J. Biol. Chem. 276 (2001) 9838-9845
7. Catalano A., Romano M., Robuffo I., Strizzi L., and Procopio A. Methionine aminopeptidase-2 regulates human mesothelioma cell survival. Am. J. Pathol. 159 (2001) 721-731
8. Liu S., Widom J., Kemp C.W., Crews C.M., and Clardy J. Structure of human methionine aminopeptidase-2 complexed with fumagillin. Science 282 (1998) 1324-1327
9. Kanno T., Endo H., Takeuchi K., Morishita Y., Fukayama M., and Mori S. High expression of methionine aminopeptidase type 2 in germinal center B cells and their neoplastic counterparts. Lab. Investigation 82 (2002) 893-901
10. Sawanyawisuth K., Wongkham C., Pairojkul C., Saeseow O.T., Riggins G.J., Araki N., and Wongkham S. Methionine aminopeptidase 2 over-expressed in cholangiocarcinoma: potential for drug target. Acta Oncol. 46 (2007) 378-385
11. Wang J., Lou P., and Henkin J. Selective inhibition of endothelial cell proliferation by fumagillin is not due to differential expression of methionine aminopeptidases. J. Cell. Biochem. 77 (2000) 465-473
12. Hannig G., Lazarus D.D., Bernier S.G., Karp R.M., Lorusso J., Qiu D., Labenski M.T., Wakefield J.D., Thompson C.D., and Westin W.F. Inhibition of melanoma tumor growth by a pharmacological inhibitor of MetAP2, PPI-2458, Intl. J. Oncol. 28 (2006) 955-963
13. Kass D., Bridges R.S., Borczuk A., and Greenberg S. Methionine aminopeptidase-2 as a selective target of myofibroblasts in pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 37 (2007) 193-201
14. Dasgupta B., Yi Y., Hegedus B., Weber J.D., and Gutmann D.H. Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma. Cancer Res. 65 (2005) 9843-9850
15. Xu G.F., O 'Connell P., Viskochil D., Cawthan R., Robertson M., Culver M., Dunn D., Stevens J., Gesteland R., White R., and Weiss R. The neurofibromatosis type I gene encodes a protein related to GAP. Cell 62 (1990) 599-608
16. Ohta S., Lai E.W., Morris J.C., Pang A.L.Y., Watanabe M., Yazawa H., Zhang R., Green J.E., Chan W.Y., Sirajuddin P., Taniguchi S., Powers J.F., Tischlet A.S., and Pacak K. Metastasis-associated gene expression profile of liver and subcutaneous lesions derived from mouse pheochromocytoma cells. Mol. Cancin. 47 (2008) 245-251
17. Powers J.F., Evinger M.J., Tsokas P., Bedris A.J., Shahvari M., and Tischler A.S. Pheochromocytoma cell lines from heterozygous neurofibromatosis knockout mice. Cell Tissue Res. 302 (2000) 309-320
18. Bo H., Ghazizadeh M., Shimizu H., Kurihara Y., Egawa S., Moriyama Y., Tajiri T., and Kawanami O. Effect on ionizing irradiation on human esophageal cancer cell lines by cDNA microarray gene expression analysis. J. Nippon. Med. Sch. 71 (2004) 172-180
19. Selvakumar P., Lakshmikuttyamma A., Kanthan R., Kanthan S.C., Dimmock J.R., and Sharma R.K. High expression of methionine aminopeptidase 2 in human colorectal adenocarcinomas. Clin. Cancer Res. 10 (2004) 2771-2775
20. Selvakumar P., Lakshmikuttyamma A., Lawman Z., Bonham K., Dimmock J.R., and Sharma R.K. Expression of methionine aminopeptidase 2, N-myristoyltransferase, and N-myristoyltransferase inhibitor protein 71 in HT29, Biochem. Biophys. Res. Commun. 322 (2004) 1012-1017
21. Tucker L.A., Zhang Q., Sheppard G.S., Lou P., Jiang F., McKeegan E., Lesniewski R., Davidsen S.K., Bell R.L., and Wang J. Ectopic expression of methionine aminopeptidase-2 causes cell transformation and stimulates proliferation. Oncogene 27 (2008) 3967-3976
22. Lefkove B., Govindarajan B., and Arbiser J.L. Fumagillin: an anti-infective as a parent molecule for novel angiogenesis inhibitors. Expert Rev. Anti Infec. Ther. 5 (2007) 573-577
23. Abe J., Zhou W., Takuwa N., Taguchi J., Kurokawa K., Kumada M., and Takuwa Y. A fumagillin derivative angiogenesis inhibitor, AGM-1470, inhibits activation of cyclin-dependent kinases and phosphorylation of retinoblastoma gene product but not protein tyrosyl phosphorylation or protooncogene expression in vascular endothelial cells. Cancer Res. 54 (1994) 3407-3412
24. 1 phase of the cell cycle. Cancer Res. 54 (1994) 2073-2076
25. Ingber D., Fujita T., Kishimoto S., Sudo K., Kanamaru T., Brem H., and Folkman J. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 348 (1990) 555-557
26. Griffith E.C., Su Z., Turk B.E., Chen S., Chang Y.H., Wu Z., Biemann K., and Liu J.O. Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin. Chem. Biol. 4 (1997) 461-471
27. Yanase T., Tamura M., Fujita K., Kodama S., and Tanaka K. Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cell lines in vitro and in vivo. Cancer Res. 53 (1993) 2566-2570
28. Yamamoto T., Sudo K., and Fujita T. Significant inhibition of endothelial cell growth in tumor vasculature by an angiogenesis inhibitor, TNP-470 (AGM-1470). Anticancer Res. 14 (1994) 1-3
29. Kusaka M., Sudo K., Fujita T., Marui S., Itoh F., Ingber D., and Filkman J. Potent anti-angiogenic action of AGM-1470: comparison to the Fumagillin parent. Biochem. Biophys. Res. Commun. 174 (1991) 1070-1076
30. Castronovo V., and Belotti D. TNP-470 (AGM-1470): mechanisms of action and early clinical development. Brit. J. Cancer 32A (1996) 2520-2527
31. Logothetis C.J., Wu K.K., Finn L.D., Daliani D., Figg W., Ghaddar H., Gutterman J.A., and Phase I. trial of the angiogenesis inhibitor, TNP-470 for progressive androgen-dependent prostate cancer. Clin. Cancer Res. 7 (2001) 1198-1203
32. Herbst R.S., Madden T.L., Tran H.T., Blumenschein G.R., Meyers C.A., Seabrooke L.F., Khuri F.R., Puduvalli V.K., Allgood V., Fritsche Jr. H.A., Hinton L., Newman R.A., Crane E.A., Fossella F.V., Dordal M., Goodin T., and Hong W.K. Safety and pharmacokinetic effects of TNP-470, an angiogenesis inhibitor combined with paclitaxel in patients with solid tumors: evidence for activity in non-small-cell lung cancer. J. Clin. Oncol. 20 (2002) 4440-4447
33. Bernier S.G., Lazarus D.D., Clark E., Doyle B., Labenske M.T., Thompson C.D., Westin W.F., Hannig G., and methionine aminopeptidase-2 inhibitor A. PPI-2458, for the treatment of rheumatoid arthritis. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 10768-10773
34. Hannig G., Bernier S.G., Hoyt J.G., Doyle B., Clark E., Karp R.M., Lorusso J., and Westin W.F. Suppression of inflammation and structural damage in experimental arthritis through molecular targeted therapy with PPI-2458. Arthritis. Rheum. 56 (2007) 850-860
35. Bainbridge J., Madden L., Essex D., Binks M., Malhotra R., and Paleolog E.M. Methionine aminopeptidase-2 blockade reduces chronic collagen-induced arthritis: potential role for angiogenesis inhibition. Arthritis Res. Ther. 9 R127 (2007) 1-13
36. WAF1/CIP1. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 6427-6432
37. CIP/WAF for endothelial cell growth arrest. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 12782-12787
38. Raman R., Chen W., and Cobb M.H. Differential regulation and properties of MAPKs. Oncogene 26 (2007) 3100-3112
39. Wang J., Tucker L.A., Stavropoulos J., Zhang Q., Wang Y.C., Bukofzer G., Niquette A., Meulbroek J.A., Barnes D.M., Jianwei S., Bouska J., Donawho C., Sheppard G.S., and Bell R.L. Correlation of tumor growth suppression and methionine aminopeptidase-2 activity blockade using an orally active inhibitor. Proc. Natl. Acad. Sci. U.S.A. 105 1838-1843 2006 (2008) 3389-3395
40. Zuo S., Guo Q., and Chang Y.H. A protease assay via precolumn derivatization and high-performance liquid chromatography. Anal. Biochem. 222 (1994) 514-516
41. Sakamoto K.M., Kim K.B., Kumagali A., Mercurio F., and Crews C.M. Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation. Proc. Natl. Acad. Sci. 98 (2001) 8554-8559
42. Yang G., Kirkpatrick R.B., Ho T., Zhang G.F., Liang P.H., Johanson K.O., Casper D.J., Doyle M.L., Marino Jr. J.P., Thompson S.K., Chen W., Tew D.G., and Meek T.D. Steady-state kinetic characterization of substrates and metal-ion specificities of the full-length and N-terminally truncated recombinant human methionine aminopeptidase (type 2). Biochemistry 40 (2001) 10645-10654
43. Roderick S.L., and Matthews B.W. Structure of the cobalt-dependent methionine aminopeptidase from Escherichia coli: a new type of proteolytic enzyme. Biochemistry 32 (1993) 3907-3912
44. Lowther W.T., and Matthews B.W. Metalloaminopeptidases: common functional themes in disparate structural surroundings. Chem. Rev. 102 (2002) 4581-4608
45. Chang Y.H., Teicher U., and Smith J.A. Purification and characterization of a methionine aminopeptidase from Saccharomyces cerevisiae. J. Biol. Chem. 265 (1990) 19892-19897
46. Chang Y.H., Teicher U., and Smith J.A. Molecular cloning, sequencing, deletion, overexpression of a methionine aminopeptidase gene from Saccharomyces cerevisiae. J. Biol. Chem. 267 (1992) 8007-8011
47. Li X., and Chang Y.H. Amino-terminal protein processing in Saccharomyces cerevisiae is an essential function that requires two distinct methionine aminopeptidases. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 12357-12361
48. Chen S., Vetro J.A., and Chang Y.H. The specificity in vivo of two distinct methionine aminopeptidases in Saccharomyces cerevisiae. Arch. Biochem. Biophys. 398 (2002) 87-93
49. Dummitt B., Micka W.S., and Chang Y.H. N-terminal methionine removal and methionine metabolism in Saccharomyces cerevisiae. J. Cell. Biochem. 89 (2003) 964-974
50. Kendall R.L., and Bradshaw R.A. Isolation and characterization of the methionine aminopeptidase from porcine liver responsible for the co-translational processing of proteins. J. Biol. Chem. 267 (1992) 20667-20673
51. Li X., and Chang Y.H. Molecular cloning of a human complementary DNA encoding an initiation factor 2-associated protein (p67). Biochem. Biophys. Acta 1260 (1995) 333-336
52. Arfin S.M., Kendall R.L., Hall L., Weaver L.H., Stewart A.E., Matthews B.W., and Bradshaw R.A. Eukaryotic methionyl aminopeptidases: two classes of cobalt-dependent enzymes. Proc. Natl. Acad. Sci., U.S.A. 92 (1995) 7714-7718
53. Durmitt B., Fei Y., and Chang Y.H. Functional expression of human methionine aminopeptidase type 1 in Saccharomyces cerevisiae. Prot. Pept. Lett. 9 (2002) 295-303
54. Wang J., Sheppard G.S., Lou P., Kawai M., BaMaung N.Y., Erickson S.A., Tucker-Garcia L., Park C., Bouska J., Wang Y.C., Frost D., Tapang P., Albert D.H., Morgan S.J., Morowitz M., Shusterman S., Maris J.M., Lesniewski R., and Henkin J. Tumor suppression by a rationally designed reversible inhibitor of methionine aminopeptidase-2. Cancer Res. 63 (2003) 7861-7869
55. J. Wang, G.S. Sheppard, P. Lou, M. Kawai, C. Park, D.A. Egan, A. Schneider, J. Bouska, R. Lesniewski, J. Henkin, Physiologically relevant metal cofactor for methionine aminopeptidase-2 is manganese, Biochemistry (42) 5035-5042.
56. Sendzik M., Jane J.W., Cabuslay R., Honigberg L., Mackman R.L., Magill C., Squires N., and Waldeck N. Design and synthesis of β-amino-α-hydroxy amide derivatives as inhibitors of MetAP2 and HUVEC growth. Bioorg. Med. Chem. Lett. 14 (2004) 3181-3184
57. Sheppard G.S., Wang J., Kawai M., BaMaung N.Y., Craig R.A., Erickson S.A., Lynch L., Pate J., Yang F., Searle X.B., Lou P., Park C., Kim K.H., Henkin J., and Lesniewski R. 3-amino-2-hydroxyamides and related compounds as inhibitors of methionine aminopeptidase-2. Bioorg. Med. Chem. Lett. 14 (2004) 865-868
58. Garrabrant T., Tuman R.W., Ludovici D., Tominovich R., and Simoneaux R.L. R.A. Galemmo Jr., D.L. Johnson, Small molecule inhibitors of methionine aminopeptidase type 2 (MetAP-2) fail to inhibit endothelial cell proliferation or formation of microvessels from rat aortic rings in vitro. Angiogenesis 7 (2004) 91-96
59. Towler D.A., Eubanks S.R., Towery D.S., Adams S.P., and Glaser L. Amino-terminal processing of proteins by N-myristoylation substrate specificity of N-myristoyltransferase. J. Biol. Chem. 262 (1987) 1030-1036
60. Turk B.E., Griffith E.C., Wolf S., Biemann K., Chang Y.H., and Liu J.O. Selective inhibition of amino-terminal methionine processing by TNP-470 and ovalicin in endothelial cells. Chem. Biol. 6 (1999) 823-833
61. Vetro J.A., and Chang Y.H. Yeast methionine aminopeptidase type 1 is ribosome-bound and requires its N-terminal zinc finger domain for normal function in vivo. J. Cell. Biochem. 85 (2002) 678-688
62. Zinker S., and Warner J.R. The ribosomal proteins of Saccharomyces cerevisiae. Phosphorylated and exchangeable proteins. J. Biol. Chem. 251 (1976) 1600-1607
63. Datta R., Choudhury P., Bhattacharya M., Leon F.S., Zhou Y., and Datta B. Protection of translation initiation factor eIF2 phosphorylation correlates with eIF2-associated glycoprotein p67 levels and requires the lysine-rich domain I of p67. Biochimie 83 (2001) 919-931
64. 67). J. Biol. Chem. 268 (1993) 10796-10801
65. Datta R., Tammali R., and Datta B. Negative regulation of the protection of eIF2α phosphorylation activity by a unique acidic domain present at the N-terminus of p67. Exp. Cell. Res. 283 (2003) 237-246
66. Datta B., and Datta R. Mutation at the acidic residue-rich domain of eukaryotic initiation factor 2 (eIF2α)-associated glycoprotein p67 increases the protection of eIF2α phosphorylation during heat shock. Arch. Biochem. Biophys. 413 (2003) 116-122
67. Datta B., Datta R., Ghosh A., and Majumdar A. The binding between p67 and eukaryotic initiation factor 2 plays important roles in the protection of eIF2α from phosphorylation by kinases. Arch. Biochem. Biophys. 452 (2006) 138-148
68. Griffith E.C., Su Z., Niwayama S., Ramsay C.A., Chang Y.H., and Liu J.O. Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 15183-15188
69. Datta B., Ghosh A., Majumdar A., and Datta R. Autoproteolysis of rat p67 generates several peptide fragments: the N-terminal fragment, p26, is required for the protection of eIF2α from phosphorylation. Biochemistry 46 (2007) 3465-3475
70. Hart G.W., Holt G.D., and Haltiwanger R.S. Nuclear and cytoplasmic glycosylation: novel saccharide linkages in unexpected places. Trends Biochem. Sci. 13 (1988) 380-384
71. Holt G.D., and Hart G.W. The subcellular distribution of terminal N-acetylglucosamine moieties. Localization of a novel protein-saccharide linkage, O-linked GlcNAc. J. Biol. Chem. 261 (1986) 8049-8057
72. 67) and its possible role in the inhibition of eIF-2 kinase-catalyzed phosphorylation of the eIF-2α-subunit. J. Biol. Chem. 264 (1989) 20620-20624
73. 63 of p67 is required for its ability to regulate the phosphorylation and activity of eukaryotic initiation factor 2α. Biochemistry 42 (2003) 5453-5460
74. Ray M.K., Datta B., Chakrabarti A., Chattopadhyay A., Meza-Keuthan S., and Gupta N.K. The eukaryotic initiation factor 2-associated 67-kDa polypeptide (p67) plays a critical role in regulation of protein synthesis initiation in animal cells. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 539-543
75. Ray M.K., Chakraborty A., Datta B., Chattopadhyay A., Saha D., Bose A., Kinzy T.G., Wu S., Hileman R.E., Merrick W.C., and Gupta N.K. Characterization of eukaryotic initiation factor 2-associated 67-kDa polypeptide. Biochemistry 32 (1993) 5151-5159
76. Chakraborty A., Saha D., Bose A., Chatterjee M., and Gupta N.K. Regulation of eIF-w2 α-subunit phosphorylation in reticulocyte lysates. Biochemistry 33 (1994) 6700-6706
77. Bose A., Saha D., and Gupta N.K. Viral infection: I. Regulation of protein synthesis during vaccinia viral infection of animal cells. Archives Biochem. Biophy. 342 (1997) 362-372
78. Saha D., Wu S., Bose A., Chatterjee N., Chakraborty A., Chatterjee M., and Gupta N.K. Viral infection: II. Hemin induces overexpression of p67 as it partially prevents appearance of an active p67-deglycosylase in baculovirus-infected insect cells. Archives Biochem. Biophy. 342 (1997) 373-382
79. 2/M boundary in human osteosarcoma cells correlates with deglycosylation of p67 and a decreased rate of protein synthesis. Exp. Cell Res. 250 (1999) 223-230
80. Yeh J.R.J., Ju R., Brdlik C.M., Zhang W., Zhang Y., Matyskiela M.E., Shotwell J.D., and Crews C.M. Targeted gene disruption of methionine aminopeptidase 2 results in an embryonic gastrulation defect and endothelial cell growth arrest. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 10379-10384
81. Boxem M., Tsai C.W., Zhang Y., Saito M., and Liu J.O. The C. elegans methionine aminopeptidase 2 analog map-2 is required for germ cell proliferation. FEBS Lett. 576 (2004) 245-250
82. Cutforth T., and Gaul U. A methionine aminopeptidase and putative regulator of translation initiation is required for cell growth and patterning in Drosophila. Mech. Dev. (1999) 23-28
83. Datta B., and Datta R. Induction of apoptosis due to lowering the level of eukaryotic initiation factor 2-associated protein, p67, from mammalian cells by antisense approach. Exp. Cell. Res. 246 (1999) 376-383
84. Ron D., and Harding H.P. elF2α phosphorylation in cellular stress responses and disease. In: Mathews M.B., Sonenberg N., and Hershey J.W.B. (Eds). Translational Control in Biology and Medicine (2006), Cold Spring Harbor Laboratories Press, Cold Spring Harbor, NY 345-368
85. Ghosh A., Datta R., Majumdar A., Bhattacharya M., and Datta B. The N-terminal lysine residue-rich domain II and the 340-430 amino acid segment of eukaryotic initiation factor 2-associated glycoprotein p67 are the binding sites for the γ-subunit of eIF2. Exp. Cell Res. 312 (2006) 3184-3202
86. Friedrich I., Ben-Bassat H., and Levitzki A. Activation of dsRNA dependent protein kinase PKR in Karpas299 does not lead to cell death. Cancer Biol. Therapy 4 (2005) 734-739
87. Nonato M.C., Widom J., and Clardy J. Crystal structure of the N-terminal segment of human eukaryotic translation initiation factor 2. J. Biol. Chem. 277 (2002) 17057-17061
88. Kim S.H., Forman A.P., Mathews M.B., and Gunnery S. Human breast cancer cells contain elevated levels and activity of the protein kinase PKR. Oncogene 19 (2000) 3086-3094
89. 51). Carcinogenesis 28 (2007) 1543-1551
90. Kim S.H., Gunnery S., Choi J.K., and Mathews M.B. Neoplastic progression in melanoma and colon cancer is associated with increased expression and activity of the interferon-inducible protein kinase. PKR, Oncogene 21 (2002) 8741-8748
91. Kip1. Plos ONE 3 (2008) e3476
92. Thiaville M.M., Pan Y.-X., Gjymishka A., Zhong C., Kaufman R.J., and Kilberg M.S. MEK signaling is required for phosphorylation of eIF2α following amino acid limitation of HepG2 human hepatoma cells. J. Biol. Chem. 283 (2008) 10848-10857
93. Mohr I.J., Pe'ery T., and Mathews M.B. Protein synthesis and translational control during viral infection. In: Mathews M.B., Sonenberg N., and Hershey J.W.B. (Eds). Translational Control in Biology and Medicine (2006), Cold Spring Harbor Laboratories Press, Cold Spring Harbor, NY 545-599
94. Chen J.-J. Heme-regulated eIF2α kinase. In: Hershey J.W.B., Mathews M.B., and Sonenberg N. (Eds). Translational Control in Gene Expression (2000), Cold Spring Harbor Laboratories Press, Cold Spring Harbor, NY 529-546
95. Hinnebusch A.G., Dever T.E., and Asano K. Mechanism of translation initiation in the yeast Saccharomyces cerevisiae. In: Mathews M.B., Sonenberg N., and Hershey J.W.B. (Eds). Translational Control in Biology and Medicine (2006), Cold Spring Harbor Laboratories Press, Cold Spring Harbor, NY 225-268
96. Skalnikova H., Vodicka P., Pelech S., Motlik J., Gadher S.J., and Kovarova H. Protein signaling pathways in differentiation of neural stem cells. Proteomics 8 (2008) 4547-4559
97. Schneider R.J. Translational control during heat shock. In: Hershey J.W.B., Mathews M.B., and Sonenberg N. (Eds). Translational Control of Gene Expression (2000), Cold Spring Harbor Laboratories Press, Cold Spring Harbor, NY 581-593
98. Wu S., Hu Y., Wang J.L., Chatterjee M., Si Y., and Kaufman R.J. Ultraviolet light inhibits translation through activation of the unfolded protein response kinase PERK in the lumen of the endoplasmic reticulum. J. Biol. Chem. 277 (2002) 18077-18083
99. Deng J., Harding P., Rought B., Gingras A.C., Berlanga J.J., Scheuner D., Kaufman R.J., Ron D., and Sonenberg N. Activation of GCN2 in UV-irradiated cells inhibits translation. Curr. Biol. 12 (2002) 1279-1286
100. Jiang H.Y., and Wek R.C. GCN2 phosphorylation of eIF2alpha activates NF-kappaB in response to UV irradiation. Biochem. J. 385 (2005) 371-380
101. L.C. Hsu, J.M. Park, K. Zhang, J.L. Luo, S. Maeda, R.J. Kaufman, L. Eckmann, D.G. Guney, M. Karin, The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4, Nature (428) 341-345.
102. Zhang P., Nicholson D.E., Bujnicki J.M., Su X., Brendle J.J., Ferdig M., Kyle D.E., Milhous W.K., and Chiang P.K. Angiogenesis inhibitors specific for methionine aminopeptidase 2 as drugs for malaria and leishmaniasis. J. Biomed. Sci. 9 (2002) 34-40